Skip to content

Clinical trials

Hemorrhagic Disorders trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Disorders Country / region: France Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20144
20162
20172
20183
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Terminated2
Active, not recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swedish Orphan Biovitrum3
BioMarin Pharmaceutical2
Genzyme, a Sanofi Company2
University Hospital, Strasbourg, France2
CNGE IRMG Association1
CTI BioPharma1
Centre Hospitalier Universitaire de Nīmes1
Diagnostica Stago R&D1
Novartis Pharmaceuticals1
Sierra Oncology LLC - a GSK company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Disorders17
Hematologic Diseases11
Blood Coagulation Disorders9
Coagulation Protein Disorders6
Genetic Diseases, Inborn6
Hemophilia A5
Blood Coagulation Disorders, Inherited4
Blood Platelet Disorders4
Bone Marrow Diseases4
Hemophilia B3

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.